Handa Pharmaceuticals. Inc. received the “Public Issuance” approval from Taiwan authorities on November 23th 2016. Stock ticker is 6620
Began operations under the new name of Handa Pharmaceuticals, Inc.
MOEA Approval of Pharmira Laoratories, Inc. as a Biotech & New Pharmaceutical Company.
Taipei City Government approved the establishment of Pharmira Laboratories, Inc., with founding equity of NTD$55 million.